copy of dr. abedin on the role of venetoclax plus obinutuzumab in cll
Published 5 years ago • 74 plays • Length 0:19Download video MP4
Download video MP3
Similar videos
-
1:01
dr. abedin on the role of venetoclax plus obinutuzumab in cll
-
1:02
dr. gerson on venetoclax/obinutuzumab combination in cll
-
7:10
the role of venetoclax rituximab in cll
-
9:15
obinutuzumab venetoclax for frontline cll
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
8:16
venetoclax and obinutuzumab in cll
-
1:56
dr. abedin discusses key updates in cll
-
1:03
dr. flinn on toxicities with venetoclax plus obinutuzumab in cll
-
2:08
the role of venetoclax in the treatment of cll
-
1:09
majic: venetoclax with acalabrutinib or obinutuzumab in cll
-
0:56
dr. dinardo on the role of venetoclax in aml
-
0:51
dr. seymour on role of ibrutinib in cll
-
1:16
dr. wierda on ibrutinib plus venetoclax in cll
-
5:54
cll14: venetoclax plus obinutuzumab for cll
-
3:52
dr. flinn on venetoclax and obinutuzumab in cll
-
1:13
dr. jones on the safety of venetoclax in cll
-
0:59
5-year follow-up results of cll14: obinutuzumab venetoclax vs obinutuzumab chlorambucil in cll
-
1:25
dr. abedin discusses differences between acalabrutinib and ibrutinib in cll
-
5:44
obinutuzumab/chlorambucil gives os benefit over rituximab in frontline cll